GlassScriptPhysician profile
Isabel Vahedi
NPI 1255435780
$3,679.44
in general payments reported to CMS, 2019-2025
9 companies · $26.93 in 2025
The $26.93 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $134 · 2021: $205 · 2022: $2,500 · 2023: $150 · 2024: $144 · 2025: $26.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,382.37 | 2019-2025 | Invisalign |
| Straumann USA LLC | $412.94 | 2019-2020 | |
| Zimvie INC. | $353.09 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $249.10 | 2019-2021 | |
| Aerin Medical INC. | $127.92 | 2024 | |
| Voco America INC. | $52.37 | 2021-2025 | Futurabond U, Voco Profluorid Varnish, Grandio So |
| Nobel Biocare USA | $51.88 | 2021 | |
| Planmeca USA, INC. | $38.12 | 2023 | Planmeca Promax |
| 3m Company | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Vahedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.